This August 7, 2014 article, “Clinical Trial Roster Shows Breadth of Ongoing Research”, gives us an idea about the current state-of-the-art as regards various new malignant mesothelioma treatments, at least those being pursued be the Mesothelioma Program at Memorial Sloan Kettering Cancer Center, in New York.
From that article, by Lee M. Krug, MD, a thoracic oncologist and Director of the Mesothelioma Program:
At Memorial Sloan Kettering, we offer a variety of clinical trials for patients with mesothelioma at all stages of their disease. These trials focus on a range of topics, from looking for genetic factors that predispose people to mesothelioma to exploring ways to combine chemotherapy, surgery, and radiation to optimize outcomes. We also have studies investigating novel therapeutic options.
This article includes discussions about and identifies some clinical studies concerning:
- Genetic Studies
- Surgery and Early-Stage Disease
- Systemic Treatments
At the end of this article there is a diagram of what is currently going on at Memorial Sloan Kettering Cancer Center as regards malignant pleural mesothelioma (MPM) treatments related clinical trial options.
Asbestos-Mesothelioma Case Evaluation Form
Free. Confidential. No Obligation.